earnings
VA
NASDAQ · VALN
Valneva SE
Healthcare · Biotechnology
$5.26
Down-$0.10 (-1.87%)
Updated Oct 25, 2026, 6:29 AM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 752.57M
- P/E ratio
- -9.07
- Dividend yield
- 0.00%
- 52-week range
- $4.75 – $12.18
- Volume
- 6.41K
- Avg. volume
- 41.67K
Price performance · VALN
VALN price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
VALN closed at $5.26 after 20 trading sessions, down 18.70% for the selected period.
- Last close
- $5.26
- Period change
- -18.70%
- Period low
- $5.26
- Period high
- $6.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $5.2573 | $5.295 | $5.25 | $5.26 | 6.41K |
| Oct 22, 2026 | $5.49 | $5.61 | $5.31 | $5.36 | 22.62K |
| Oct 21, 2026 | $5.75 | $5.75 | $5.5301 | $5.56 | 137.26K |
| Oct 20, 2026 | $5.54 | $5.84 | $5.54 | $5.69 | 13.1K |
| Oct 19, 2026 | $5.53 | $5.53 | $5.40 | $5.51 | 9.14K |
| Oct 16, 2026 | $5.87 | $5.87 | $5.58 | $5.61 | 9.48K |
| Oct 15, 2026 | $5.84 | $5.91 | $5.77 | $5.91 | 8.68K |
| Oct 14, 2026 | $5.66 | $5.73 | $5.61 | $5.66 | 22.52K |
| Oct 13, 2026 | $5.89 | $5.89 | $5.55 | $5.56 | 28.75K |
| Oct 12, 2026 | $5.86 | $5.96 | $5.85 | $5.93 | 10.52K |
| Oct 9, 2026 | $5.81 | $5.81 | $5.73 | $5.78 | 5.61K |
| Oct 8, 2026 | $5.612 | $5.74 | $5.612 | $5.69 | 11.26K |
| Oct 7, 2026 | $5.8676 | $5.99 | $5.8676 | $5.87 | 26.27K |
| Oct 6, 2026 | $6.04 | $6.04 | $5.78 | $5.86 | 19.06K |
| Oct 5, 2026 | $5.89 | $5.985 | $5.70 | $5.815 | 69.38K |
| Oct 2, 2026 | $5.84 | $5.8931 | $5.73 | $5.74 | 39.84K |
| Oct 1, 2026 | $6.05 | $6.075 | $5.90 | $5.90 | 34.51K |
| Sep 30, 2026 | $6.19 | $6.27 | $6.16 | $6.185 | 5.84K |
| Sep 29, 2026 | $6.36 | $6.36 | $6.125 | $6.14 | 9.63K |
| Sep 28, 2026 | $6.25 | $6.49 | $6.225 | $6.47 | 21.57K |
Latest VALN news
The latest Smart Investors Daily articles mentioning VALN.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

